Financhill
Buy
56

STRO Quote, Financials, Valuation and Earnings

Last price:
$1.05
Seasonality move :
0.48%
Day range:
$0.99 - $1.08
52-week range:
$0.52 - $5.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
1.97x
Volume:
1.1M
Avg. volume:
2M
1-year change:
-72.58%
Market cap:
$88M
Revenue:
$62M
EPS (TTM):
-$3.02

Earnings Data

Next earnings date for STRO
May 13
2025
Most recent earnings per share
-$0.89
Beat by $0.07
(Mar 13/2025)
Consensus Estimate
-$0.96
(Mar 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

STRO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $11.5M -- -- -- --
05/13/2025 Q1 $11.6M -- -- -- --
03/13/2025 Q4 $12.2M $14.8M -$0.89 -$0.96 $0.07
11/13/2024 Q3 $15.3M $8.5M -$0.59 -$0.74 $0.15
08/13/2024 Q2 $21M $25.7M -$0.59 -$0.90 $0.31
05/13/2024 Q1 $12.1M $13M -$0.95 -$1.00 $0.05
03/25/2024 Q4 $13.2M $113.7M $0.52 -$0.84 $1.36
11/13/2023 Q3 -- -- -$0.81 -$0.72 -$0.09
08/10/2023 Q2 -- -- -$0.64 -$0.69 $0.05
05/15/2023 Q1 -- -- -$0.85 -$0.75 -$0.10
03/30/2023 Q4 -- -- -$0.61 -$0.63 $0.02
11/08/2022 Q3 -- -- -$0.37 $0.01 -$0.38
08/08/2022 Q2 -- -- -$0.55 -$0.77 $0.22
05/09/2022 Q1 -- -- -$0.84 -$0.74 -$0.10
02/28/2022 Q4 -- -- -$0.83 -$0.76 -$0.07
11/10/2021 Q3 -- -- -$0.67 -$0.48 -$0.19
08/09/2021 Q2 -- -- -$0.13 -$0.40 $0.27
05/07/2021 Q1 -- -- -$0.66 -$0.60 -$0.06
03/18/2021 Q4 -- -- -$1.90 -$0.48 -$1.42
11/05/2020 Q3 -- -- $0.45 -$0.50 $0.95
08/06/2020 Q2 -- -- $0.94 -$0.57 $1.51
05/11/2020 Q1 -- -- -$0.84 -$0.57 -$0.27
03/16/2020 Q4 -- -- -$0.64 -$0.66 $0.02
11/08/2019 Q3 -- -- -$0.56 -$0.62 $0.06
08/14/2019 Q2 -- -- -$0.60 -$0.60 $0.00
04/01/2019 Q1 -- -- -$0.62 -$0.61 -$0.01
12/31/2018 Q4 -- -- -$0.07 -$0.67 $0.60
11/14/2018 Q3 -- -- -$0.43 $1.97 -$2.40

Sutro Biopharma Earnings Questions

  • How Much did Sutro Biopharma Generate in Revenue Last Quarter?

    Sutro Biopharma reported $14.8M worth of top line sales in its most recent quarter.

  • Did Sutro Biopharma Beat Earnings Last Quarter?

    Sutro Biopharma announced earnings per share of -$0.89 which represents a beat of analyst forecast a -$0.96 per share.

  • Is Sutro Biopharma Profitable?

    Sutro Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Sutro Biopharma EPS Next Year?

    Sutro Biopharma's earnings are forecast to decrease from -$2.96 per share to -$3.07 per share next year representing a decrease of -16.22%.

  • When is Sutro Biopharma's Earnings Date?

    Sutro Biopharma's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Is RTX The Best Growth Stock?
Is RTX The Best Growth Stock?

Among the worldwide aerospace and defense markets, the US controls…

Is VFS Stock Cheap to Buy Now?
Is VFS Stock Cheap to Buy Now?

VinFast Auto (NASDAQ:VFS) is a leading EV manufacturer in Vietnam.…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
86
TRUP alert for May 6

Trupanion [TRUP] is down 0.38% over the past day.

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 53.44% over the past day.

Sell
35
XYZ alert for May 6

Block [XYZ] is up 0.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock